Press Releases

 Filter by Provider

Franklin Covey Co. (NYSE: FC), a leader in organizational performance improvement that creates and distributes world-class content, training, processes, and tools that organizations and individuals use to achieve systemic changes in human behavior to transform their results, today announced its financial results for the first quarter of fiscal 2026, which ended on November 30, 2025.

The Beachbody Company, Inc. (NASDAQ: BODI) (“BODi” or the “Company”), a leading fitness and nutrition company, today announced that Mark Goldston, Executive Chairman, Carl Daikeler, Co-Founder and Chief Executive Officer and Brad Ramberg, Interim Chief Financial Officer will present at the 2026 ICR Conference in Orlando, Florida on Monday, January 12, 2026, at 11:30am EST.

Collaborative pilot at Kuji facility showcases robust ethanol yields using LanzaTech’s fermentation technology

Jumio, the leading provider of AI-powered identity intelligence anchored in biometric authentication, automation, and data-driven insights, today announced that Bala Kumar has been appointed president and interim chief executive officer, effective immediately. Kumar succeeds Robert Prigge, who is departing after nearly a decade of leadership and a period of meaningful growth and progress for the company.

New end-to-end system combines opportunity discovery, real-time alerts, proposal drafting, and award-history insights; includes free SAMextension Chrome tool to guide SAM.gov registration

The 42nd Harbin International Ice and Snow Festival commenced on January 5, once again transforming the capital of northeast China’s Heilongjiang Province into a global stage for winter culture and international exchange.

Antwerp, Jan. 07, 2026 (GLOBE NEWSWIRE) -- CMB.TECH NV (“CMBT”, “CMB.TECH” or “the Company”) (NYSE: CMBT, Euronext Brussels: CMBT and Euronext Oslo Børs: CMBTO) has sold eight vessels, generating a capital gain of approximately 269.2 million USD in total.

Today, entrepreneur and operations manager Mya Murdock announced a new personal pledge aimed at strengthening community food security and expanding awareness of local meal programs. The pledge reflects her lifelong connection to volunteer work, her upbringing on a 500-acre farm in rural upstate New York, and her continued commitment to self-sufficiency, empathy, and community support.

Iconic Houston trial lawyer Mark Lanier has been inducted into the Lawdragon Hall of Fame class of 2026.

Permian Resources Corporation (NYSE: PR) (“Permian Resources,” “we,” or the “Company”) announced today that it has completed its previously disclosed corporate reorganization, pursuant to which Permian Resources’ management team members and certain other long-term holders exchanged Class C shares for Class A shares. This transaction better aligns management ownership with public investors, enhances the ability of management team members to maintain peer-leading ownership and advances Permian Resources towards the simplification of its current Up-C structure.

Resources Connection, Inc. (Nasdaq: RGP) (the “Company”), a professional services firm, today announced its financial results for its second quarter of fiscal 2026 ended November 29, 2025.

FuboTV Inc. (NYSE: FUBO) today announced that no holders of Fubo’s Convertible Senior Secured Notes due 2029 tendered their notes for repurchase.

F5, Inc. (NASDAQ: FFIV), the global leader in delivering and securing every app and API, announced it will report its first quarter fiscal year 2026 financial results on Tuesday, January 27, 2026, following the market close. F5 will host a live webcast to discuss its results with investors and analysts beginning at 4:30 p.m. ET on January 27, 2026.

Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases, today outlined its 2026 priorities for casdatifan and its emerging inflammation and immunology (I&I) programs.

Terreno Realty Corporation (NYSE:TRNO), an acquirer, owner and operator of industrial real estate in six major coastal U.S. markets, announced today its operating, investment and capital markets activity for the fourth quarter of 2025.

Kilroy Realty Corporation (NYSE: KRC) ("Kilroy" or the “Company”) announced today it will release fourth quarter 2025 financial results after the market closes on Monday, February 9, 2026. Kilroy will hold a conference call to discuss the results at 10:00 a.m. PT / 1:00 p.m. ET on Tuesday, February 10, 2026.

Diodes Incorporated (Nasdaq: DIOD), today announced the Company will participate virtually in the 28th Annual Needham Growth Conference on Thursday, January 15, 2026 and will be available to host scheduled conference calls with participating investors throughout the day.

AppLovin Corporation, (NASDAQ: APP) (“AppLovin” or the “Company”) the leading marketing platform, today announced it will report financial results for the fourth quarter and fiscal year 2025 on Wednesday, February 11, 2026 after the U.S. stock market closes.

Rocky Brands, Inc. (NASDAQ: RCKY) today announced that the management team is participating in the 2026 ICR Conference. A fireside chat presentation is scheduled for Monday, January 12, 2026, at 2:30 p.m. Eastern Time. The presentation will be simultaneously broadcast on the internet and will be available at https://investors.rockybrands.com.

DoorDash, Inc. (NASDAQ: DASH) today announced that the company’s fourth quarter and full year 2025 financial results will be released after the U.S. financial markets close on Wednesday, February 18, 2026. The company’s earnings press release will be made available on the DoorDash Investor Relations website at ir.doordash.com.

New York, NY, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Twelve Seas Investment Company III (Nasdaq: TWLVU) (the “Company”) announced today that, commencing January 9, 2026, holders of the units sold in the Company’s initial public offering may elect to separately trade the Company’s Class A ordinary shares and rights included in the units. The Class A ordinary shares and rights that are separated will trade on the Nasdaq Global Market under the symbols “TWLV” and “TWLVR,” respectively. Those units not separated will continue to trade on the Nasdaq Global Market under the symbol “TWLVU.”

Abivax Provides 2026 Corporate Outlook

Mr. Dewhurst Brings Over 30 Years of Life Sciences and M&A Experience to the Board, Aligning with the Company’s Strategic Long-Term Goals for Growth and Expansion

Five9, Inc. (NASDAQ:FIVN), provider of the Intelligent CX Platform, today announced that members of its management team will present at the following investor conference:

CARDINAL Phase 1/2 trial of TERN-701 enrolling well, with multiple important milestones in 2026

WALTHAM, Mass., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Crane NXT, Co. (NYSE: CXT), a premier industrial technology company, announced that Aaron Saak, President and Chief Executive Officer, and Christina Cristiano, Senior Vice President and Chief Financial Officer, will participate in a fireside chat at the CJS Securities 26th Annual New Ideas for the New Year Conference on Wednesday, January 14, 2026 at 8:45 a.m. ET. 

CHARLOTTE, N.C., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Terrestrial Energy Inc. (NASDAQ: IMSR) (“Terrestrial Energy” or “the Company”), a developer of small modular nuclear power plants using its Generation IV reactor technology, announced today that it will participate in the 28th Annual Needham Growth Conference on Tuesday, January 13, 2026, in New York, NY.

FLORHAM PARK, N.J., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, announced today that it intends to offer and sell, subject to market and other conditions, shares of its common stock or, in lieu of common stock to certain investors that so choose, pre-funded warrants to purchase shares of its common stock, in an underwritten public offering. In addition, Phathom intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the total number of the securities offered in the public offering. There can be no assurance as to whether or when the proposed offering may be completed, or as to the actual size or terms of the offering. 

BRISBANE, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that impact nearly 10 million people worldwide, today announced that Douglas Love, president and chief executive officer, will present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026 at 11:15 a.m. PST.

SOUTH SAN FRANCISCO, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living with inflammatory and immunological diseases, today announced that Brian Wong, M.D., Ph.D., President and Chief Executive Officer, will present a company overview at the 44thAnnual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026 at 2:15 p.m. Pacific Time.

NOVATO, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultra-rare genetic diseases, today announced that Emil D. Kakkis, M.D., Ph.D., the company's chief executive officer and president, will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026, at 10:30 AM PT.

FRAMINGHAM, Mass., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare market data and analytics, today announced that its Chief Financial Officer, Casey Heller, will present at the 28th Annual Needham Growth Conference.

ROCHESTER, N.Y., Jan. 07, 2026 (GLOBE NEWSWIRE) --  Constellation Brands, Inc. (NYSE: STZ), a leading beverage alcohol company, reported today its third quarter fiscal 2026 financial results. A conference call to discuss the financial results and outlook will be hosted by President and Chief Executive Officer, Bill Newlands, and Chief Financial Officer, Garth Hankinson, on Thursday, January 8, 2026 at 10:30 a.m. ET. Visit ir.cbrands.com to locate information for joining the conference call, or a live, listen-only webcast of the conference call.

The Harbin International Ice and Snow Economy Expo 2026 opened on January 6 in Harbin, capital of northeast China’s Heilongjiang Province, showcasing cutting-edge achievements of the ice-and-snow industry.

Zehl & Associates, the nationally acclaimed personal injury and wrongful death law firm, has been recognized for securing a record-setting $37.5 million wrongful death verdict against Oncor Electric Delivery Company following a deadly crash in Dallas. TopVerdict.com named the case one of the Top 50 Wrongful Death Verdicts in the United States for 2024.

NEW YORK - Panxo has launched the public version of its AI traffic monetization platform, purpose-built to help publishers monetize visitors referred by conversational AI assistants. The company says it is the first infrastructure platform designed specifically to turn conversational AI referrals into measurable revenue for publishers.

Coastal States Bank (“CSB”) marked a significant milestone, ringing the Opening Bell at the New York Stock Exchange (NYSE) in celebration of the initial public offering (IPO) and official listing of its holding company, CoastalSouth Bancshares, Inc. (NYSE: COSO). The opening bell was rung by the company’s Chairman, Jim MacLeod and President and Chief Executive Officer, Stephen R. Stone, who were joined on the podium by members of the bank’s board of directors and senior leadership team.

Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a leading rare disease company, today announced that it will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Wednesday, January 14, 2026 at 11:15 a.m. PT.

Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the 45th annual J.P. Morgan Healthcare Conference in San Francisco. Senior leadership will present on behalf of the Company on Monday, January 12th, 2026 at 9:00 AM Pacific Standard Time.

FLORHAM PARK, N.J., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, today announced certain preliminary unaudited financial results for the fourth quarter and full year ended December 31, 2025.Preliminary Fourth Quarter 2025 Financial Results

WESTLAKE VILLAGE, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Genelux Corporation (“Genelux”) (Nasdaq: GNLX), a late clinical-stage immuno-oncology company, today announced that it has commenced a proposed underwritten public offering of its common stock. In addition, Genelux expects to grant the underwriter a 30-day option to purchase up to an additional 15% of the number of shares of common stock sold in connection with the proposed offering. All shares are being offered by Genelux. The proposed offering is subject to market and other customary closing conditions, and there can be no assurance as to whether or when the proposed offering may be completed, or as to the actual size or terms of the proposed offering.

BOSTON, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, Inc. (“Monte Rosa”) (Nasdaq: GLUE), a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines, today announced that it has commenced an underwritten public offering of $200.0 million of shares of its common stock and, in lieu of common stock to certain investors, pre-funded warrants to purchase shares of common stock. All of the shares of common stock and pre-funded warrants to purchase shares of common stock in the proposed offering are to be sold by Monte Rosa. Monte Rosa also intends to grant the underwriters a 30-day option to purchase up to an additional $30.0 million of shares of its common stock. The proposed offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

Preventogen™ eradicated Candida auris antibiotic-resistant strain by 99.99% at 30, 90 and 120 seconds with a formidable 5.61 log reduction.

First Business Financial Services, Inc. (the “Company” or “First Business Bank”) (Nasdaq:FBIZ) invites participation in a conference call to discuss the Company’s financial and operating performance during its fourth quarter ended December 31, 2025. The conference call and webcast may contain forward-looking statements and other material information.

Tetra Tech, Inc. (NASDAQ: TTEK), a leading provider of high-end consulting and engineering services in water, environment, and sustainable infrastructure, announced today the planned dates for its first quarter 2026 results and conference call.

Singapore, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Republic Power Group Limited (“RPGL” or the “Company”), (NASDAQ: RPGL) announced today that on January 5, 2026, the Company received a notification letter from the Nasdaq Listing Qualifications Staff of The NASDAQ Stock Market LLC (“Nasdaq”), notifying the Company that the minimum bid price per share for its Class A ordinary shares has been below $1.00 for a period of 30 consecutive business days and the Company therefore no longer meets the minimum bid price requirements set forth in Nasdaq Listing Rule 5550(a)(2).

PHILADELPHIA, PA, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Art Technology Acquisition Corp. (NASDAQ:ARTCU) (the “Company”) today announced the closing of its initial public offering of 22,000,000 units. The offering was priced at $10.00 per unit, resulting in gross proceeds to the Company of $220,000,000. The Company has granted the underwriter a 45-day option to purchase up to an additional 3,300,000 units at the initial public offering price to cover over-allotments, if any.

DENVER, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Pure Cycle Corporation (NASDAQ Capital Market: PCYO) (“Pure Cycle”, “we”, “us” or “our”) announced its financial results for the three months ended November 30, 2025. Pure Cycle reported $4.5 million of net income for the three months ended November 30, 2025, which is a 16% increase in net income from the same period in 2024 and marks the twenty-sixth consecutive fiscal quarter with positive net income. Pure Cycle reported $0.19 of earnings per fully diluted common share, which is up from $0.16 in the same period in 2024, a 19% increase. Pure Cycle continues to see demand for entry level lots at our Sky Ranch Master Planned Community despite national headwinds in homebuilding. By partnering with our national home builders, we deliver finished lots on an annual cadence that allows for steady absorption while navigating cyclical housing industry trends.

- Reported 12-month overall survival (OS) in Phase 2a clinical trial nearly double the benchmark from pivotal study of standard of care gemcitabine/nab-paclitaxel (GnP) -